Vilya in the news

Cyclic peptide structure prediction and design using AlphaFold2

Our scientific founder, Dr. David Baker, has been awarded the 2024 Nobel Prize in Chemistry for his pioneering work in computational protein design. The science behind Vilya’s mission builds directly upon Dr. Baker’s original discovery by applying advanced computational approaches to design novel, chemically diverse macrocycles to target disease biology with unprecedented precision.

Vilya Announces New Publication in Science Validating Foundational Approach to Design of Novel Chemically Diverse Macrocycles

Vilya Appoints Cyrus Harmon, Ph.D., as Chief Executive Officer

CELL: Accurate de novo design of membrane-traversing macrocycles

IPD spinout Vilya computing new paths to oral macrocycle therapies